EUVIMEDEUVIMED entdecken
Beobachtungsstudie

Age distribution and prevalence in different age groups of four myositis‐specific autoantibodies, including anti‐ARS , anti‐MDA5 , anti‐Mi ‐2, and anti‐TIF1γ antibodies

Ikuko Ueda-Hayakawa iD, Kyoko Tonomura iD, Aya Maekawa, Emi Kaneda, Noriko Arase iD, Manabu Fujimoto

The Journal of Dermatology · 2023-08 · 50 (8) · 1058-1062

DOI: 10.1111/1346-8138.16772 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift The Journal of Dermatology, online erschienen am 08.03.2023. Verfasst von Ikuko Ueda-Hayakawa und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Osaka University Graduate School of Medicine, Suita, Japan. Hauptthemen laut MEDLINE: Amino Acyl-tRNA Synthetases, Dermatomyositis, Myositis. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 14 Literaturangaben. Gefördert von: a grant of Research on Intractable Diseases from the Ministry of Health, Labor, and Welfare of Japan.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We accumulated the demographic information and analyzed the prevalence of myositis‐specific antibodies (MSAs) in a large cohort across Japan as standard testing for MSAs becomes more widely available. This retrospective, observational, cohort study analyzed the records of individuals aged 0–99 years who are tested for serum MSAs at SRL Incorporation from January 2014 to April 2020 across Japan. An enzyme‐linked immunosorbent assay testing was applied to determine the presence of anti‐aminoacyl tRNA synthetase (anti‐ARS), anti‐Mi‐2, anti‐melanoma differentiation‐associated gene 5 (anti‐MDA5), or anti‐transcriptional intermediary factor 1‐γ (anti‐TIF1γ) (Medical and Biological Laboratories). Anti‐TIF1γ antibody was detected more in male patients than female patients. In contrast, women were predominant in patients with other MSAs. More than half of the anti‐ARS or anti‐TIF1γ antibody‐positive patients were over 60 years old, although anti‐MDA5 or anti‐Mi‐2‐positive patients were mostly under 3‐year evaluation of MSA detection in a routine diagnostic setting. This paper provides clinical images concerning the relationship between four MSA types and the distribution of sex and age in a large population.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Amino Acyl-tRNA SynthetasesDermatomyositisMyositisAdolescentAdultChildChild, PreschoolFemaleHumansInfantInfant, NewbornMaleMiddle AgedYoung AdultAge DistributionAutoantibodiesCohort StudiesPrevalenceRetrospective StudiesAged

Stichwörter der Autor:innen

anti-ARS antibodyanti-MDA5 antibodyanti-Mi-2 antibodyanti-TIF1γ antibodyidiopathic inflammatory myopathymyositis-specific antibody

Substanzen

Amino Acyl-tRNA SynthetasesAutoantibodiesMi-2 antibodies

Autor:innen und Institutionen

  • Department of Dermatology, Osaka University Graduate School of Medicine, Suita, Japan.

ORCID-Profile: Ikuko Ueda-Hayakawa, Kyoko Tonomura, Noriko Arase

Förderung

  • a grant of Research on Intractable Diseases from the Ministry of Health, Labor, and Welfare of Japan

Zitieren

APA

Ueda-Hayakawa, I., Tonomura, K., Maekawa, A., Kaneda, E., Arase, N., & Fujimoto, M. (2023). Age distribution and prevalence in different age groups of four myositis‐specific autoantibodies, including anti‐ARS , anti‐MDA5 , anti‐Mi ‐2, and anti‐TIF1γ antibodies. The Journal of Dermatology, 50(8), 1058-1062. https://doi.org/10.1111/1346-8138.16772

Vancouver

Ueda-Hayakawa I, Tonomura K, Maekawa A, Kaneda E, Arase N, Fujimoto M. Age distribution and prevalence in different age groups of four myositis‐specific autoantibodies, including anti‐ARS , anti‐MDA5 , anti‐Mi ‐2, and anti‐TIF1γ antibodies. The Journal of Dermatology. 2023;50(8):1058-1062. doi:10.1111/1346-8138.16772

BibTeX
@article{UedaHayakawa2023,
  author = {Ueda-Hayakawa, Ikuko and Tonomura, Kyoko and Maekawa, Aya and Kaneda, Emi and Arase, Noriko and Fujimoto, Manabu},
  title = {Age distribution and prevalence in different age groups of four myositis‐specific autoantibodies, including anti‐ARS , anti‐MDA5 , anti‐Mi ‐2, and anti‐TIF1γ antibodies},
  journal = {The Journal of Dermatology},
  year = {2023},
  volume = {50},
  number = {8},
  pages = {1058--1062},
  doi = {10.1111/1346-8138.16772}
}
Kostenlos starten →